Capricor Therapeutics reported $-6371000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Bluebird Bio BLUE:US USD -76513000 16.99M
Capricor Therapeutics CAPR:US USD -6371000 738K
Cytokinetics CYTK:US USD -142310000 122.49M
Cytori Therapeutics CYTX:US USD -5219000 63K
Geron GERN:US USD -41051000 12.93M
Johnson & Johnson JNJ:US USD 7.42B 655M
Newlink Genetics NLNK:US USD -7251000 593K
Prothena PRTA:US USD -48417000 5.84M
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Vascular Biogenics VBLT:US USD -9170000 264K
Vital Therapies VTL:US USD -21224000 677K